Home » Authors » Mark McCarty

Articles by Mark McCarty

Endovalve percutaneous valve poised as 1st in mitral position

Oct. 29, 2007

By Mark McCarty

EPs push expansion of pacing to earlier heart failure stages

Oct. 26, 2007

By Mark McCarty

‘Evidence,’ but what’s best kind in med-tech clinical trial court?

Oct. 25, 2007

By Mark McCarty

Cytori says business model for Celution as strong as research

Oct. 24, 2007

By Mark McCarty

Xtent, upbeat about multi-vessel DES, takes on sector crowding

Oct. 23, 2007

By Mark McCarty

Panel says roller coaster ride may finally be over for DES

Oct. 23, 2007

By Mark McCarty

Comments prompt CMS reversal on clinical trial coverage denial

Oct. 19, 2007

By Mark McCarty

San Diego chosen as first site for CMS lab bidding project

Oct. 18, 2007

By Mark McCarty

CMS set to roll out P4P demo project for home healthcare

Oct. 17, 2007

By Mark McCarty

Panel shoots down non-RCTs, this time for carotid stenting

Oct. 15, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...